(Q30896811)

27 June 2017

1 reference

title

Specialization of tumour vasculature (English)

1 reference

27 June 2017

1

Erkki Ruoslahti

1 reference

PubMed ID

12635171

27 June 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

27 June 2017

Nature Reviews Cancer

1 reference

27 June 2017

2

1 reference

27 June 2017

83-90

1 reference

27 June 2017

2

1 reference

Targeting tumor vasculature with homing peptides from phage display

27 June 2017

1 reference

LYVE-1, the lymphatic system and tumor lymphangiogenesis

21 January 2018

1 reference

Vasculogenic mimicry and tumor angiogenesis

21 January 2018

1 reference

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry

21 January 2018

1 reference

Vasculogenic mimicry: how convincing, how novel, and how significant?

21 January 2018

1 reference

Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood

21 January 2018

1 reference

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

21 January 2018

The Hallmarks of Cancer

1 reference

Clinical applications of angiogenic growth factors and their inhibitors

21 January 2018

1 reference

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

21 January 2018

1 reference

The Eugene M. Landis Award Lecture 1996. Delivery of molecular and cellular medicine to solid tumors

21 January 2018

1 reference

Openings between defective endothelial cells explain tumor vessel leakiness

21 January 2018

1 reference

Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis

21 January 2018

1 reference

VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer

21 January 2018

1 reference

Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development

21 January 2018

1 reference

Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis

21 January 2018

1 reference

The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization

21 January 2018

1 reference

Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization.

21 January 2018

1 reference

Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells

21 January 2018

1 reference

Lack of specificity of endoglin expression for tumor blood vessels.

21 January 2018

1 reference

21 January 2018

1 reference

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin

21 January 2018

1 reference

Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins

21 January 2018

1 reference

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

21 January 2018

1 reference

The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development.

21 January 2018

1 reference

Expression of antisense to integrin subunit beta 3 inhibits microvascular endothelial cell capillary tube formation in fibrin

21 January 2018

1 reference

Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins

21 January 2018

1 reference

The adaptor protein Shc couples a class of integrins to the control of cell cycle progression

21 January 2018

1 reference

A signaling pathway from the alpha5beta1 and alpha(v)beta3 integrins that elevates bcl-2 transcription

21 January 2018

1 reference

Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins

21 January 2018

1 reference

Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.

21 January 2018

1 reference

Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain

21 January 2018

1 reference

Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization

21 January 2018

1 reference

Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo

21 January 2018

1 reference

A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis

21 January 2018

1 reference

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

21 January 2018

1 reference

A novel approach for the identification of unique tumor vasculature binding peptides using an E. coli peptide display library

21 January 2018

1 reference

Labeling and distribution of linear peptides identified using in vivo phage display selection for tumors

21 January 2018

1 reference

Solution structures and integrin binding activities of an RGD peptide with two isomers

21 January 2018

1 reference

CD13/APN is activated by angiogenic signals and is essential for capillary tube formation

21 January 2018

1 reference

Genes expressed in human tumor endothelium

21 January 2018

1 reference

NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis

21 January 2018

1 reference

Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer

21 January 2018

1 reference

Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium

21 January 2018

1 reference

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

21 January 2018

1 reference

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

21 January 2018

1 reference

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

21 January 2018

1 reference

Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3

21 January 2018

1 reference

Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry

21 January 2018

1 reference

Trophoblast pseudo-vasculogenesis: faking it with endothelial adhesion receptors

21 January 2018

1 reference

Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents

21 January 2018

1 reference

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging

21 January 2018

1 reference

Anti-cancer activity of targeted pro-apoptotic peptides

21 January 2018

1 reference

Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).

21 January 2018

1 reference

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins

21 January 2018

1 reference

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

31 March 2020

1 reference

Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase

31 March 2020

1 reference

The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis

31 March 2020

1 reference

In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease

31 March 2020

1 reference

Anatomic distribution of intraprostatic lymphatics: implications for the lymphatic spread of prostate cancer-a preliminary study

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC724

1 reference

PubMed ID

12635171

Dimensions Publication ID

27 June 2017

0 references

1 reference

PubMed ID

12635171